David H. Altreuter - Concepedia

Author

David H. Altreuter

Also Known As

David Altreuter, David H Altreuter, David H. Altreuter

Publications

867

Citations

H-Index

Concepts

All Affiliations

David H. Altreuter is an author at Selecta Biosciences (United States) specializing in t cell immunity, biomedical engineering, and autoimmunity.

#	Concept	H-Index	Publications	Citations
1	Engineering	2	2	607
2	Medicine	2	2	502
3	Allergy	2	2	502
4	Biomedical Engineering	2	2	607
5	Cell Biology	1	1	81

David H. Altreuter

Publications

864

Citations

H-Index

Page 1

	Year	Citations
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance Roberto Maldonado, Robert A. LaMothe, Joseph D. Ferrari, Proceedings of the National Academy of Sciences NanoparticlesEngineeringCurrent TreatmentsImmunologyBiomedical Engineering	2014	421
Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles Takashi Kishimoto, Joseph D. Ferrari, Robert A. LaMothe, Nature Nanotechnology NanoparticlesEngineeringTherapeutic NanomaterialsBiologic DrugsTolerogenic Nanoparticles	2016	186
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release Petr O. Ilyinskii, Chad J. Roy, Conlin P. O’Neil, Vaccine	2014	160
Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates Christopher C. Fraser, David H. Altreuter, Petr O. Ilyinskii, Vaccine T-regulatory CellImmunologyCd4t CellsImmunologic MechanismAntigen Processing	2014	81
Development and preclinical evaluation of SEL-068, a novel <i>targeted</i> Synthetic Vaccine Particle ( <i>t</i> SVP™) for smoking cessation and relapse prevention that generates high titers of antibodies against nicotine (75.11) Lynnelle A. Pittet, David H. Altreuter, Petr O. Ilyinskii, The Journal of Immunology	2012	16

Page 1